Zenith Health

{
  "main_header": {
    "sid": 841083,
    "name": "Zenith Health",
    "stock_name": "Zenith Health",
    "full_name": "Zenith Health Care Ltd",
    "name_url": "stocks-analysis/zenith-health",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.03",
    "chg": -0.07,
    "chgp": "-2.26%",
    "dir": -1,
    "prev_price": "3.10",
    "mcapval": "17.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530665,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE812B01026",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "31.7 k",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenith-health-841083-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zenith Health Care Ltd Stock Falls to 52-Week Low of Rs.3.02",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-stock-falls-to-52-week-low-of-rs302-3865477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZenithHealthCar_priceRelatedfactors_3865477.png",
        "date": "2026-03-02 14:20:13",
        "description": "Zenith Health Care Ltd’s share price declined sharply to a new 52-week low of Rs.3.02 on 2 Mar 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns."
      },
      {
        "title": "Zenith Health Care Ltd Valuation Shifts Signal Price Attractiveness Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-valuation-shifts-signal-price-attractiveness-concerns-3863459",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZenithHealthCar_valuationdot_3863459.png",
        "date": "2026-03-02 08:00:40",
        "description": "Zenith Health Care Ltd’s valuation metrics have shifted notably, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving the stock into an expensive category relative to its historical averages and peer group. Despite a stagnant share price and underwhelming returns compared to the Sensex, the company’s deteriorating financial performance and valuation upgrade to ‘expensive’ raise questions about its price attractiveness for investors."
      },
      {
        "title": "Zenith Health Care Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-valuation-shifts-signal-changing-market-sentiment-3852021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenithHealthCar_valuationdot_3852021.png",
        "date": "2026-02-24 08:02:18",
        "description": "Zenith Health Care Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, marks a significant development for investors assessing the pharmaceutical and biotechnology sector’s micro-cap landscape."
      },
      {
        "title": "Zenith Health Care Ltd Valuation Shifts Signal Elevated Price Risk Amid Weak Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-valuation-shifts-signal-elevated-price-risk-amid-weak-returns-3841704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenithHealthCar_valuationdot_3841704.png",
        "date": "2026-02-16 08:04:44",
        "description": "Zenith Health Care Ltd has seen a marked shift in its valuation parameters, moving from a risky to an expensive rating, reflecting a significant change in price attractiveness. Despite a modest day gain of 0.60%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, when compared to historical averages and peer benchmarks, suggest caution for investors amid deteriorating fundamentals and a challenging sector backdrop."
      },
      {
        "title": "Are Zenith Health Care Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zenith-health-care-ltd-latest-results-good-or-bad-3838267",
        "imagepath": "",
        "date": "2026-02-13 20:03:31",
        "description": "Zenith Health Care Ltd's latest financial results for Q3 FY26 indicate a quarter of operational improvement, although the overall performance must be contextualized within the company's historical challenges. The company reported a net profit of ₹0.22 crores, marking a significant increase from the previous quarter, while revenue also saw a quarter-on-quarter growth of 9.25%, reaching ₹2.48 crores. This revenue growth is a recovery from a prior decline, reflecting a positive sequential momentum.\n\nThe operating margin improved to 10.89%, the highest recorded in the past eight quarters, suggesting better cost management and operational efficiency. Additionally, the PAT margin expanded to 8.87%, indicating a notable improvement in profitability metrics. However, it is essential to recognize that these results come after a period of volatility, where the company has experienced fluctuations between profits and ..."
      },
      {
        "title": "Zenith Health Care Q3 FY26: Micro-Cap Pharma Shows Signs of Life Amid Persistent Challenges",
        "link": "https://www.marketsmojo.com/news/result-analysis/zenith-health-care-q3-fy26-micro-cap-pharma-shows-signs-of-life-amid-persistent-challenges-3837856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenithHealthCar_quaterlyResult_3837856.png",
        "date": "2026-02-13 10:11:07",
        "description": "Zenith Healthcare Limited posted a net profit of ₹0.22 crores in Q3 FY26, marking a sequential improvement of 57.14% from Q2 FY26's ₹0.14 crores, though the micro-cap pharmaceutical manufacturer continues to grapple with structural challenges that have plagued its financial performance for years. The Ahmedabad-based company, with a modest market capitalisation of ₹18.00 crores, reported revenue of ₹2.48 crores for the quarter, representing a 9.25% sequential uptick but only a modest 7.36% year-on-year gain. Despite the quarterly profit surge reaching its highest level in recent quarters, the stock has languished, trading at ₹3.36—down 34.76% over the past year and hovering just 10.16% above its 52-week low of ₹3.05."
      },
      {
        "title": "When is the next results date for Zenith Health Care Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-zenith-health-care-ltd-3819163",
        "imagepath": "",
        "date": "2026-02-03 23:17:16",
        "description": "The next results date for Zenith Health Care Ltd is scheduled for 12 February 2026...."
      },
      {
        "title": "Why is Zenith Health Care Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-zenith-health-care-ltd-fallingrising-3779317",
        "imagepath": "",
        "date": "2026-01-03 01:49:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Zenith Health Care Ltd’s stock price has demonstrated a significant upward trajectory over the past week, gaining 7.58% compared to the Sensex’s modest 0.85% rise during the same period. This outperformance extends to the year-to-date (YTD) returns, where Zenith Health Care has surged by 10.15%, substantially eclipsing the Sensex’s 0.64% gain. The stock’s recent momentum is further underscored by a consecutive two-day gain, signalling renewed investor confidence after a prolonged period of underperformance.</p>\n<p>Despite this recent rally, it is important to note that Zenith Health Care’s longer-term performance remains subdued. Over the past year, the stock has declined by 33.03%, contrasting sharply with the Sensex’s 7.28% appreciat..."
      },
      {
        "title": "Zenith Health Care Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenith-health-care-ltd-is-rated-strong-sell-3771219",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ZenithHealthCar_mojoScore_3771219.png",
        "date": "2025-12-26 15:12:03",
        "description": "Zenith Health Care Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 February 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 26 December 2025, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 95,
    "sid": "841083",
    "stock_news_url": "https://www.marketsmojo.com/news/zenith-health-care-841083"
  },
  "announcements": [
    {
      "caption": "Outcome Of Board Meeting",
      "datetime": "12-Feb-2026",
      "details": "Un-Audited Financial Result for the Quarter ended on 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "12-Feb-2026",
      "details": "Un-Audited Financial Results For The Quarter Ended On 31St December 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday February 12 2026",
      "datetime": "02-Feb-2026",
      "details": "Zenith Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Tuesday February 12 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zenith Health Care Ltd Stock Falls to 52-Week Low of Rs.3.02

2026-03-02 14:20:13

Zenith Health Care Ltd’s share price declined sharply to a new 52-week low of Rs.3.02 on 2 Mar 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns.

Read full news article

Zenith Health Care Ltd Valuation Shifts Signal Price Attractiveness Concerns

2026-03-02 08:00:40

Zenith Health Care Ltd’s valuation metrics have shifted notably, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving the stock into an expensive category relative to its historical averages and peer group. Despite a stagnant share price and underwhelming returns compared to the Sensex, the company’s deteriorating financial performance and valuation upgrade to ‘expensive’ raise questions about its price attractiveness for investors.

Read full news article

Zenith Health Care Ltd Valuation Shifts Signal Changing Market Sentiment

2026-02-24 08:02:18

Zenith Health Care Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, marks a significant development for investors assessing the pharmaceutical and biotechnology sector’s micro-cap landscape.

Read full news article

Zenith Health Care Ltd Valuation Shifts Signal Elevated Price Risk Amid Weak Returns

2026-02-16 08:04:44

Zenith Health Care Ltd has seen a marked shift in its valuation parameters, moving from a risky to an expensive rating, reflecting a significant change in price attractiveness. Despite a modest day gain of 0.60%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, when compared to historical averages and peer benchmarks, suggest caution for investors amid deteriorating fundamentals and a challenging sector backdrop.

Read full news article

Are Zenith Health Care Ltd latest results good or bad?

2026-02-13 20:03:31

Zenith Health Care Ltd's latest financial results for Q3 FY26 indicate a quarter of operational improvement, although the overall performance must be contextualized within the company's historical challenges. The company reported a net profit of ₹0.22 crores, marking a significant increase from the previous quarter, while revenue also saw a quarter-on-quarter growth of 9.25%, reaching ₹2.48 crores. This revenue growth is a recovery from a prior decline, reflecting a positive sequential momentum. The operating margin improved to 10.89%, the highest recorded in the past eight quarters, suggesting better cost management and operational efficiency. Additionally, the PAT margin expanded to 8.87%, indicating a notable improvement in profitability metrics. However, it is essential to recognize that these results come after a period of volatility, where the company has experienced fluctuations between profits and ...

Read full news article

Zenith Health Care Q3 FY26: Micro-Cap Pharma Shows Signs of Life Amid Persistent Challenges

2026-02-13 10:11:07

Zenith Healthcare Limited posted a net profit of ₹0.22 crores in Q3 FY26, marking a sequential improvement of 57.14% from Q2 FY26's ₹0.14 crores, though the micro-cap pharmaceutical manufacturer continues to grapple with structural challenges that have plagued its financial performance for years. The Ahmedabad-based company, with a modest market capitalisation of ₹18.00 crores, reported revenue of ₹2.48 crores for the quarter, representing a 9.25% sequential uptick but only a modest 7.36% year-on-year gain. Despite the quarterly profit surge reaching its highest level in recent quarters, the stock has languished, trading at ₹3.36—down 34.76% over the past year and hovering just 10.16% above its 52-week low of ₹3.05.

Read full news article

When is the next results date for Zenith Health Care Ltd?

2026-02-03 23:17:16

The next results date for Zenith Health Care Ltd is scheduled for 12 February 2026....

Read full news article

Why is Zenith Health Care Ltd falling/rising?

2026-01-03 01:49:16

Recent Price Movement and Market Context

Zenith Health Care Ltd’s stock price has demonstrated a significant upward trajectory over the past week, gaining 7.58% compared to the Sensex’s modest 0.85% rise during the same period. This outperformance extends to the year-to-date (YTD) returns, where Zenith Health Care has surged by 10.15%, substantially eclipsing the Sensex’s 0.64% gain. The stock’s recent momentum is further underscored by a consecutive two-day gain, signalling renewed investor confidence after a prolonged period of underperformance.

Despite this recent rally, it is important to note that Zenith Health Care’s longer-term performance remains subdued. Over the past year, the stock has declined by 33.03%, contrasting sharply with the Sensex’s 7.28% appreciat...

Read full news article

Zenith Health Care Ltd is Rated Strong Sell

2025-12-26 15:12:03

Zenith Health Care Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 February 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 26 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

View All News